The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis.

Phonophoresis is the use of ultrasound (US) to enhance the delivery of topically applied drugs. The purposes of this article are (1) to review the basic principles of transcutaneous drug delivery, (2) to summarize the functional anatomy of the skin pertinent to phonophoresis, (3) to outline the physiological principles of US as an enhancer of topically applied drugs, (4) to review the literature on the efficacy of phonophoresis, (5) to discuss the relevance of US as an enhancer of topical drugs in the practice of physical therapy, and (6) to outline areas of needed research. Seventy-five percent of the studies reviewed reported positive effects of US on local subcutaneous drug diffusion, but some systemic effects were reported. This research review indicates that to maximize the clinical effectiveness of phonophoresis: (1) the topical drug (both the drug and the carrying agent) should transmit US; (2) the skin should be pretreated with US, heating, moistening, or shaving; (3) the patient needs to be positioned to maximize circulation during treatment; (4) a dressing that seals the area and prevents the escape of moisture should be applied after treatment; (5) an intensity of 1.5 W/cm2 should be used to capture both the thermal and nonthermal effects of the US; and (6) low-intensity US (0.5 W/cm2) should be used when treating open wounds or acute injuries. Research is needed to clarify what parameters of US will most efficiently facilitate topical drug diffusion, how often and for what duration US should be used to maximize local absorption of drugs, and which topical drugs can most effectively be used for phonophoresis.

[1]  M. Miller,et al.  Absence of mitotic reduction in regenerating rat livers exposed to ultrasound , 1976, Journal of clinical ultrasound : JCU.

[2]  R. MacKie Clinical Dermatology: An Illustrated Textbook , 1981 .

[3]  F. Winn,et al.  Comparative Study using Four Modalities in Shinsplint Treatments*. , 1986, The Journal of orthopaedic and sports physical therapy.

[4]  J. T. Newman,et al.  Hydrocortisone phonophoresis. A literature review. , 1992, Journal of the American Podiatric Medical Association.

[5]  J. Echternach,et al.  Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. , 1967, Physical therapy.

[6]  N. Byl,et al.  The effects of phonophoresis with corticosteroids: a controlled pilot study. , 1993, The Journal of orthopaedic and sports physical therapy.

[7]  M. Dyson,et al.  Stimulation of tissue repair by ultrasound: a survey of the mechanisms involved. , 1978, Physiotherapy.

[8]  A. R. Williams Phonophoresis: an in vivo evaluation using three topical anaesthetic preparations. , 1990, Ultrasonics.

[9]  Romanenko Im,et al.  Comparative levels of amphotericin B in the skin and subcutaneous fatty tissue after cutaneous application of amphotericin ointment by phonophoresis and with preliminary treatment by dimethyl sulfoxide , 1991 .

[10]  P. Elias The importance of epidermal lipids for the stratum corneum Barrier , 1990 .

[11]  J. Richardson,et al.  Effectiveness of 10% trolamine salicylate cream on muscular soreness induced by a reproducible program of weight training. , 1989, The Journal of orthopaedic and sports physical therapy.

[12]  J. Griffin,et al.  ULTRASONIC MOVEMENT OF CORTISOL INTO PIG TISSUE. II. MOVEMENT INTO PARAVERTEBRAL NERVE. , 1965, American journal of physical medicine.

[13]  A. R. Williams Ultrasound : biological effects and potential hazards , 1983 .

[14]  J. Griffin,et al.  ULTRASONIC MOVEMENT OF CORTISOL INTO PIG TISSUES I. MOVEMENT INTO SKELETAL MUSCLE , 1963, American journal of physical medicine.

[15]  J. Lehmann,et al.  Therapeutic temperature distribution produced by ultrasound as modified by dosage and volume of tissue exposed. , 1967, Archives of physical medicine and rehabilitation.

[16]  R. Scheuplein,et al.  Percutaneous absorption of steroids. , 1969, The Journal of investigative dermatology.

[17]  A. Ward,et al.  Penetration Enhancer Incorporation in Bilayers , 1988 .

[18]  J. McElnay,et al.  The effect of ultrasound on the percutaneous absorption of lignocaine. , 1985, British journal of clinical pharmacology.

[19]  R. Potts,et al.  Lipid biophysics of water loss through the skin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Novak Ej EXPERIMENTAL TRANSMISSION OF LIDOCAINE THROUGH INTACT SKIN BY ULTRASOUND. , 1964 .

[21]  F. P. Magee,et al.  Comparison of ultrasonically applied vs. intra-articular injected hydrocortisone levels in canine knees. , 1990, Orthopaedic review.

[22]  P. Dittrich,et al.  Spontaneous and forced cutaneous absorption of indomethacin in pigs and humans. , 1986, The Journal of rheumatology.

[23]  R H Guy,et al.  Drug delivery to local subcutaneous structures following topical administration. , 1983, Journal of pharmaceutical sciences.

[24]  J. Griffin,et al.  Low-intensity phonophoresis of cortisol in swine. , 1968, Physical therapy.

[25]  L A Crum,et al.  The significance of membrane changes in the safe and effective use of therapeutic and diagnostic ultrasound. , 1989, Physics in medicine and biology.

[26]  T. J. Antich Phonophoresis: the principles of the ultrasonic driving force and efficacy in treatment of common orthopaedic diagnoses. , 1982, The Journal of orthopaedic and sports physical therapy.

[27]  L. Hollister,et al.  Studies of delayed‐action medication , 1965 .

[28]  H. Kimata,et al.  Percutaneous absorption and anti‐inflammatory activity of indomethacin in ointment , 1982, The Journal of pharmacy and pharmacology.

[29]  M. L. Godeau,et al.  [The skin]. , 1977, Soins; la revue de reference infirmiere.

[30]  B. L. Karalfa,et al.  Utilization of hydrocortisone phonophoresis in United States Army Physical Therapy Clinics. , 1989, Military medicine.

[31]  J. Albright,et al.  Distribution and deposition of tritiated cortisol using phonophoresis. , 1988, Physical therapy.

[32]  J. A. Kleinkort,et al.  Phonophoresis with 1 percent versus 10 percent hydrocortisone. , 1975, Physical therapy.

[33]  J. McElnay,et al.  Use of ultrasound to enhance percutaneous absorption of benzydamine. , 1989, Physical therapy.

[34]  Linda G. Monroe,et al.  Relative transmission of ultrasound by media customarily used for phonophoresis. , 1992, Physical therapy.

[35]  D. Miller,et al.  Platelet aggregation induced by ultrasound under specialized conditions in vitro. , 1979, Science.

[36]  B. Carlson,et al.  Myotoxicity of Local Anesthetics and Regeneration of the Damaged Muscle Fibers , 1980, Anesthesia and analgesia.

[37]  G. Frampton,et al.  Effects of ultrasound alone and combined with hydrocortisone injections by needle or hypo-spray. , 1958, American journal of physical medicine.

[38]  J. McElnay,et al.  The influence of ultrasound on the percutaneous absorption of fluocinolone acetonide , 1987 .

[39]  M. Barbanoj,et al.  Anti-inflammatory activity of piroxicam after oral and topical administration on an ultraviolet-induced erythema model in man , 1988 .

[40]  J Kost,et al.  Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. , 1989, The Journal of clinical investigation.

[41]  H. Maibach,et al.  In Vitro Percutaneous Absorption: Principles, Fundamentals, and Applications , 1991 .